about
Characteristics of individuals presenting to treatment for primary alcohol problems versus other drug problems in the Australian patient pathways study.Anhedonia in substance use disorders: a systematic review of its nature, course and clinical correlates.Implications of Eligibility Criteria on the Generalizability of Alcohol and Drug Treatment Outcome Research: A Study of Real-World Treatment Seekers in Sweden and in Australia.Social disadvantage and past treatment among clients entering public alcohol and drug services in two Australian states.Substance use outcomes following treatment: Findings from the Australian Patient Pathways Study.Psychometric properties, validity, and reliability of the Temporal Experience of Pleasure Scale state version in an opioid-dependent sample.Evidence that anhedonia is a symptom of opioid dependence associated with recent use.The effects of FG7142 on overexpectation of Pavlovian fear conditioning.Problem gambling and substance use in patients attending community mental health services.Attention to pleasant stimuli in early adolescence predicts alcohol-related problems in mid-adolescence.Money well-spent: Further evidence of improved outcomes for methamphetamine users following treatment.Cognitive Bias Modification Training During Inpatient Alcohol Detoxification Reduces Early Relapse: A Randomized Controlled Trial.Dynamic associations between opioid use and anhedonia: A longitudinal study in opioid dependenceProtocol for a randomised controlled trial of cognitive bias modification training during inpatient withdrawal from alcohol use disorderRelationship between measures of impulsivity in opioid-dependent individualsPrescribed sedative and other psychotropic medication use among clients attending alcohol and other drug treatmentImproved Quality of Life Following Addiction Treatment Is Associated with Reductions in Substance UseFeasibility and acceptability of approach bias modification during methamphetamine withdrawal and related methamphetamine use outcomesThe influence of opioid dependence on salt consumption and related psychological parameters in mice and humans
P50
Q36082057-20A3467A-841A-4B1E-9D20-76E5F9C10C23Q38165682-EB2288F9-797B-41A1-8758-43A4092062C6Q39183888-AD8DDFB2-83F6-4AEB-8E6A-A8C7680382C2Q40048085-A1B4243F-ADA8-4875-B95A-48902A27F789Q40105406-C88BE5E8-C318-49EB-B0B0-EA87B7414B51Q44335669-8286E06A-3CC3-447D-BFD2-5F78102277E7Q44345993-BAAA414D-0CE3-4000-BBEB-8B5EACCB01B6Q46146685-F74E8CDD-518C-4738-A2EB-718DEB18F74CQ47562970-17119540-E8C9-408C-B76C-6534734E3A90Q47724983-6EFC5A20-4129-42D4-9BB0-2E2B7DD06ABFQ50206402-D7E095D3-3CD8-455A-9C90-A7187127E96AQ50494262-7E0112CA-30CE-46CC-8405-CD0F91EABBCEQ57838895-A3C232EB-1250-4490-BCFD-A04E42433391Q58085590-95C0B7DC-4A56-4927-A5D0-DF9BC6981669Q60681238-007E2C44-86DC-47BC-BB34-76B86A62964EQ89468229-97B25FB3-2C3B-4E9A-A24A-05E3ADE5D6C6Q89994584-F23517E0-7C4D-4709-B64B-5E4E29D588DBQ90195478-E9320967-8DE1-4BAB-BA9B-861D6D458164Q92541781-033DE007-5495-4AD4-98CC-3D7FB4A8A8E3
P50
description
researcher ORCID ID = 0000-0002-5076-6499
@en
wetenschapper
@nl
name
Joshua B.B. Garfield
@ast
Joshua B.B. Garfield
@en
Joshua B.B. Garfield
@es
Joshua B.B. Garfield
@nl
type
label
Joshua B.B. Garfield
@ast
Joshua B.B. Garfield
@en
Joshua B.B. Garfield
@es
Joshua B.B. Garfield
@nl
prefLabel
Joshua B.B. Garfield
@ast
Joshua B.B. Garfield
@en
Joshua B.B. Garfield
@es
Joshua B.B. Garfield
@nl
P108
P1153
55322495100
P31
P496
0000-0002-5076-6499